Loading organizations...
KBL Healthcare Ventures operates as KBL Healthcare Acquisition Corp. III, a Special Purpose Acquisition Company (SPAC) merging with private healthcare businesses. Its core offering transitions these companies into publicly traded entities, targeting valuations from $110M to over $500M. This mechanism provides liquidity and growth capital for development.
KBL Healthcare Acquisition Corp. III formed in July 2007 after its IPO. This venture leverages KBL's long track record of successful SPAC transactions, demonstrating expertise in facilitating public market access. The driving insight is that well-positioned private healthcare firms can significantly scale with strategic capitalization.
The firm serves private healthcare businesses seeking public market access and expansion funding. Mergers provide immediate liquidity and considerable future upside through sustained ownership. KBL’s vision focuses on fostering robust growth and supporting strategic acquisitions for its partner companies in the evolving healthcare sector.
KBL Healthcare Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $15.0M Series G in Neuronetics in June 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2017 | Neuronetics | $15.0M Series G | — | Access Biotechnology, Atlas Venture, Borealis Ventures, Flagship Ventures, GE Ventures, InterWest, SR ONE, Vivo Capital, Wildcat Ventures, Timothy A. Springer, Accuitive Medical Ventures, Rubal Bedi, Industry Ventures, Interwest Partners, Investor Growth Capital, NEW Leaf Venture Partners, ONSET Ventures, Pfizer, Polaris Partners, Three Arch Partners |
| Mar 6, 2007 | PneumRx | $27.0M Series B | Adams Street Partners, Telegraph Hill Partners | Alta Partners, Sage Venture Partners, Spray Venture Partners |
